Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on S Citalopram Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Deep dive into CN104072390B. Advanced impurity control for S-escitalopram. Reliable supply chain and cost-effective manufacturing solutions for global pharma.
Advanced enzymatic and chemical separation process for high-purity escitalopram intermediates. Reduces manufacturing costs and improves supply chain reliability for global API producers.
Patent CN102796065A details a novel resolution and cyclization route for S-escitalopram, offering superior optical purity and simplified manufacturing for global pharmaceutical supply chains.
Novel resolution method using ethyl acetate and ethanol mixtures ensures high optical purity and yield for scalable antidepressant intermediate production.